Insider Transactions last 24 months for Amylyx Pharmaceuticals, Inc.  -  NSDQ: AMLX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Bedrosian Camille LChief Medical Officer03/05/2026AADirectCOM95,990$0.00$0.00265,285
Klee Justin B.Co-Chief Executive Officer03/05/2026AADirectCOM248,865$0.00$0.003,583,481
Frates James MChief Financial Officer03/05/2026AADirectCOM95,990$0.00$0.00261,628
Mazzariello GinaChief Legal Officer03/05/2026AADirectCOM74,660$0.00$0.00209,090
Cohen Joshua BCo-Chief Executive Officer03/05/2026AADirectCOM248,865$0.00$0.003,583,548
Mazzariello GinaChief Legal Officer03/02/2026DSDirectCOM6,844$14.52$99,378.30134,430
Frates James MChief Financial Officer03/02/2026DSDirectCOM7,909$14.52$114,851.33165,638
Bedrosian Camille LChief Medical Officer03/02/2026DSDirectCOM6,461$14.58$94,205.26169,295
Cohen Joshua BCo-Chief Executive Officer03/02/2026DSDirectCOM29,282$14.48$424,120.493,334,683
Klee Justin B.Co-Chief Executive Officer03/02/2026DSDirectCOM29,282$14.47$423,760.323,334,616
Mazzariello GinaChief Legal Officer02/23/2026DSDirectCOM3,419$14.14$48,352.18141,274
Klee Justin B.Co-Chief Executive Officer02/02/2026DSDirectCOM15,500$14.69$227,617.503,363,898
Mazzariello GinaChief Legal Officer02/02/2026DSDirectCOM3,448$14.65$50,515.61144,693
Cohen Joshua BCo-Chief Executive Officer02/02/2026DSDirectCOM15,500$14.68$227,592.703,363,965
Frates James MChief Financial Officer02/02/2026DSDirectCOM3,557$14.65$52,096.89173,547
Klee Justin B.Co-Chief Executive Officer01/16/2026DSDirectCOM1,995$13.89$27,701.173,379,398
Klee Justin B.Co-Chief Executive Officer01/16/2026AMDirectCOM2,847$7.57$21,551.793,381,393
Cohen Joshua BCo-Chief Executive Officer01/16/2026DSDirectCOM1,974$13.83$27,299.043,379,465
Cohen Joshua BCo-Chief Executive Officer01/16/2026AMDirectCOM2,818$7.57$21,332.263,381,439
Klee Justin B.Co-Chief Executive Officer01/15/2026DSDirectCOM136,193$13.58$1,849,868.663,378,546
Klee Justin B.Co-Chief Executive Officer01/15/2026AMDirectCOM197,153$7.57$1,492,448.213,514,739
Cohen Joshua BCo-Chief Executive Officer01/15/2026DSDirectCOM136,193$13.59$1,850,794.773,378,621
Cohen Joshua BCo-Chief Executive Officer01/15/2026AMDirectCOM197,182$7.57$1,492,667.743,514,814
Milne George M JrDirector01/12/2026DGDirectCOM17,780$0.00$0.00812,881
Klee Justin B.Co-Chief Executive Officer01/06/2026DSDirectCOM7,715$11.09$85,589.443,317,586
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel